Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	18.46B +19.3%
Revenue (ttm)	9.50B -17.8%
Net Income	891.15M -14.0%
EPS	0.77 -13.0%
Shares Out	1.13B
PE Ratio	21.17
Forward PE	14.39
Dividend	0.59 (3.58%)
Ex-Dividend Date	Apr 29, 2026

Volume	6,738,826
Average Volume	14,644,472
Open	16.47
Previous Close	16.40
Day's Range	16.23 - 16.57
52-Week Range	13.58 - 19.59
Beta	0.34
RSI	38.15
Earnings Date	Apr 21, 2026

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd researches and develops, produces, and sells pharmaceutical products in China and internationally. It provides products in the cardio-cerebrovascular, anti-infection, anti-viral, anti-tumor, and other treatment areas. The company offers preparations, raw material intermediates, and veterinary drugs primarily under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. It also provides contract research and development, and production services for pharmaceutical companies. The company is headquartered in Dongyang...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 6,787
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2025, SHE:000739's revenue was 9.78 billion, a decrease of -18.62% compared to the previous year's 12.02 billion. Earnings were 890.68 million, a decrease of -13.62%.